The BioMedWire Podcast

IBN , a multifaceted communications organization engaged in connecting public companies to the investment community, is pleased to announce the release of the latest episode of  The BioMedWire Podcast as part of its sustained effort to provide specialized content distribution via widespread syndication channels. The BioMedWire Podcast showcases fast-paced interviews with industry experts pioneerin...

IBN , a multifaceted communications organization engaged in connecting public companies to the investment community, is pleased to announce the release of the latest episode of  The BioMedWire Podcast as part of its sustained effort to provide specialized content distribution via widespread syndication channels. The BioMedWire Podcast showcases fast-paced interviews with industry experts pioneerin...

The BioMedWire Podcast features fast-paced interviews with experts guiding the next wave of pharmaceutical and biotech innovation. The latest episode features Amir Reichman, CEO of Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) , a biopharmaceutical company focused on developing inflammation and immunology biological products and on providing CDMO services through its Scinai Bioservices business un...

The BioMedWire Podcast features fast-paced interviews with experts guiding the next wave of pharmaceutical and biotech innovation. The latest episode features Amir Reichman, CEO of Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) , a biopharmaceutical company focused on developing inflammation and immunology biological products and on providing CDMO services through its Scinai Bioservices business un...

The latest episode features John Climaco, CEO of CNS Pharmaceuticals Inc. (NASDAQ: CNSP) , a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system. To begin the interview, Climaco discussed CNS Pharmaceuticals’ business model, including the company’s recent announcement of an exclusive in-license agr...

The latest episode features John Climaco, CEO of CNS Pharmaceuticals Inc. (NASDAQ: CNSP) , a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system. To begin the interview, Climaco discussed CNS Pharmaceuticals’ business model, including the company’s recent announcement of an exclusive in-license agr...

The latest episode features Rob Etherington, President and CEO of Clene Inc. (NASDAQ: CLNN) , a late clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases. To begin the interview, Etherington discussed Clene’s mission, including its novel approach to the treatment of diseases such as amyotrophic later...

The latest episode features Rob Etherington, President and CEO of Clene Inc. (NASDAQ: CLNN) , a late clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases. To begin the interview, Etherington discussed Clene’s mission, including its novel approach to the treatment of diseases such as amyotrophic later...

The latest BioMedWire podcast features Dr. Maria Maccecchini, Ph. D., Founder, President, and CEO of Annovis Bio Inc. (NYSE: ANVS) , a late-stage clinical drug platform company pioneering transformative therapies for neurodegenerative diseases such as Alzheimer’s disease (AD) and Parkinson’s disease (PD). Broadcasting live from AAIC 2024, Dr. Maccecchini delves into the detailed findings from Anno...

The latest BioMedWire podcast features Dr. Maria Maccecchini, Ph. D., Founder, President, and CEO of Annovis Bio Inc. (NYSE: ANVS) , a late-stage clinical drug platform company pioneering transformative therapies for neurodegenerative diseases such as Alzheimer’s disease (AD) and Parkinson’s disease (PD). Broadcasting live from AAIC 2024, Dr. Maccecchini delves into the detailed findings from Anno...

The BioMedWire Podcast features fast-paced interviews with experts guiding the next wave of pharmaceutical and biotech innovation. The latest episode features Amir Reichman, CEO of Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) , a biopharmaceutical company focused on developing inflammation and immunology biological products and on providing CDMO services through its Scinai Bioservices business un...

Conservative alt-coin podcast hosts Drew Taylor and Brent Bates recently welcomed guests and the audience to another episode of their wildly popular Wild West Crypto Show. The program took a somber turn to delve into current events in Afghanistan and remember service members and people who’ve given their lives for this country. The hosts split segments normally reserved for guests to discuss how g...

Conservative alt-coin podcast hosts Drew Taylor and Brent Bates recently welcomed guests and the audience to a lively episode of their wildly popular Wild West Crypto Show. The program delved into “another week at the speed of crypto.” “Folks, let me tell you something. If you’re not diversified, out of just cash, out of just the stock market,” Taylor said, shooting straight with some cowboy frien...

CryptoCurrencyWire’s Jonathan Keim shared the latest and greatest in the world of cryptocurrencies, as well as special guest Greg Magarshak, the founder of Intercoin, and his team to discuss their project. “Intercoin was started with a vision that any community in the world — churches, yoga studios, also cities and universities — can have their own coin, their own currency,” Magarshak said, respon...

CryptoCurrencyWire’s Jonathan Keim’s take on the latest trends in the world of cryptocurrencies. The Look and Learn segment further featured discussion surrounding the 24-hour globalization of crypto. “Crypto is 24/7. Its lights are on all the time,” Bates said, describing the nuances of cryptocurrency trading. “What a lot of people don’t realize is, with crypto, you’re not only your own complianc...

CryptoCurrencyWire’s Jonathan Keim then shined the spotlight on the latest and greatest in the world of cryptocurrencies. Perhaps the most authentically wild part of the show was spent on the hosts’ takes on the recent crazy ride of cryptos. Taylor described cryptos of late as “bucking like bodacious” and asked viewers whether they stayed on for the eight-second ride or ran for the fences. Bates t...

Crypto Currency Wire Communications Director, Jonathan Keim on The Wild West Crypto Show Episode 161 | BTC Taking in the Shorts, BUT Alt Coins are Rising BroadcastMay 14, 2021. The latest news from around the cryptocurrency/blockchain space with Crypto Currency Wire's Communications Director, Jonathan Keim. The Wild West Crypto Show is the brainchild of Drew Taylor. Drew created this platform as a...

CryptoCurrencyWire’s Jonathan Keim shared the latest and greatest happenings in the world of cryptocurrencies. Richard Heart also joined the program to discuss the HEX project. “The government just prints money out of thin air,” Heart said. “The price of everything just shoots up through the roof. We’ve got all-time highs in the stock market, all-time highs in cryptocurrencies, all-time highs in g...

Crypto Currency Wire Communications Director, Jonathan Keim on The Wild West Crypto Show Episode 158 | Carnomaly Listed on KuCoin Broadcast Apr 23, 2021. The latest news from around the cryptocurrency/blockchain space with Crypto Currency Wire's Communications Director, Jonathan Keim. The Wild West Crypto Show is the brainchild of Drew Taylor. Drew created this platform as a tool to inform people...

Conservative alt-coin podcast hosts Drew Taylor and Brent Bates recently welcomed guests and the audience to a lively episode of their wildly popular Wild West Crypto Show. The program featured CryptoCurrencyWire’s Jonathan Keim, in a segment appropriately deemed as “Keim Time,” to highlight the latest and greatest happenings in the world of cryptocurrencies. Kristin Boggiano, the president of Cro...

CryptoCurrencyWire’s Jonathan Keim also joined the program to highlight the latest and greatest in the world of cryptocurrencies. The show additionally welcomed in-house special guest — the late Rush Limbaugh’s cousin, Andy Limbaugh. Andy shined the spotlight on the early days of Rush’s career when he started “just really taking off” in the late 1989, early 1990 timeframe. Rush was concerned about...

CryptoCurrencyWire’s Jonathan Keim discusses the growing adoption of digital currencies. Keim also shines a spotlight on the latest and greatest innovations, including Crypto.com’s Visa card, which is the most widely available of its kind in the world. Justin Renken, the new sponsor for the show’s Daily Country Mile Update, also rounds up some exciting discussion surrounding the ARK project. “Thes...

Crypto Currency Wire Communications Director, Jonathan Keim on The Wild West Crypto Show Episode 154 | Trader Heaven, Markets Bouncing Like Superball Broadcast March 26, 2021. The latest news from around the cryptocurrency/blockchain space with Crypto Currency Wire's Communications Director, Jonathan Keim. The Wild West Crypto Show is the brainchild of Drew Taylor. Drew created this platform as a...

Crypto Currency Wire Communications Director, Jonathan Keim on The Wild West Crypto Show Episode 153 | Explosion of Cryptos, Deeper Network’s Exciting DPN Project Broadcast Mar 23, 2021. The latest news from around the cryptocurrency/blockchain space with Crypto Currency Wire's Communications Director, Jonathan Keim. The Wild West Crypto Show is the brainchild of Drew Taylor. Drew created this pla...

Crypto Currency Wire Communications Director, Jonathan Keim on The Wild West Crypto Show Episode 152 | Golf Tournament to Raise Parkinson’s Awareness Broadcast Mar 16, 2021. The latest news from around the cryptocurrency/blockchain space with Crypto Currency Wire's Communications Director, Jonathan Keim. The Wild West Crypto Show is the brainchild of Drew Taylor. Drew created this platform as a to...